Manulife (Manufacturers Life Insurance)
IMVT icon

Manulife (Manufacturers Life Insurance)’s Immunovant IMVT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Sell
51,421
-45,813
-47% -$1.19M ﹤0.01% 1706
2025
Q4 		$2.47M Buy
97,234
+61,341
+171% +$1.37M ﹤0.01% 1439
2025
Q3 		$579K Sell
35,893
-231
-0.6% -$3.74K ﹤0.01% 2146
2025
Q2 		$578K Buy
36,124
+900
+3% +$13.6K ﹤0.01% 2108
2025
Q1 		$602K Sell
35,224
-684
-2% -$14.3K ﹤0.01% 2051
2024
Q4 		$889K Sell
35,908
-772
-2% -$21.9K ﹤0.01% 1962
2024
Q3 		$1.05M Sell
36,680
-946
-3% -$27.9K ﹤0.01% 1902
2024
Q2 		$993K Sell
37,626
-39,877
-51% -$1.13M ﹤0.01% 1866
2024
Q1 		$2.5M Buy
77,503
+15,156
+24% +$553K ﹤0.01% 1441
2023
Q4 		$2.63M Buy
62,347
+730
+1% +$26.9K ﹤0.01% 1386
2023
Q3 		$2.37M Buy
61,617
+38,238
+164% +$864K ﹤0.01% 1386
2023
Q2 		$444K Sell
23,379
-27,246
-54% -$508K ﹤0.01% 2117
2023
Q1 		$785K Buy
50,625
+20,191
+66% +$350K ﹤0.01% 1750
2022
Q4 		$536K Buy
+30,434
New +$383K ﹤0.01% 1944
2022
Q2 		– Sell
-20,276
Closed -$112K – 3068
2022
Q1 		$112K Sell
20,276
-4,235
-17% -$26.4K ﹤0.01% 2945
2021
Q4 		$209 Buy
24,511
+87
+0.4% +$718 ﹤0.01% 2865
2021
Q3 		$212K Buy
24,424
+2,011
+9% +$18.1K ﹤0.01% 2941
2021
Q2 		$237K Sell
22,413
-266
-1% -$3.71K ﹤0.01% 2985
2021
Q1 		$364K Buy
22,679
+51
+0.2% +$1.34K ﹤0.01% 2484
2020
Q4 		$1.04M Buy
22,628
+3,511
+18% +$162K ﹤0.01% 1789
2020
Q3 		$673K Buy
19,117
+8,000
+72% +$241K ﹤0.01% 1847
2020
Q2 		$283K Buy
+11,117
New +$238K ﹤0.01% 2295

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IMVT Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Immunovant (IMVT) stake by 47% in Q1 2026, selling an estimated $1.19M and leaving 51,421 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

Manulife (Manufacturers Life Insurance) first reported a position in IMVT in Q2 2020 and has held it in 22 quarters since. The position peaked at $2.63M in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 51,421 shares of Immunovant worth $1.28M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 45,813 Immunovant shares in Q1 2026, an estimated $1.19M.
  • Immunovant made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1706 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Immunovant in Q2 2020 and has held it in 22 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Immunovant position peaked at $2.63M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.